Description
SARMS® Myostatin, 70 mg
SARMS® Myostatin 70 mg refers to YK-11 (Myostine), a compound commonly marketed in the SARM category because of its activity at the androgen receptor and its research interest surrounding follistatin and myostatin-related muscle-growth pathways. YK-11 is structurally unusual compared with conventional non-steroidal SARMs, but its combination of androgen-receptor activity and myogenic signaling makes it particularly interesting for advanced bodybuilding and muscle-development research.
How it works
YK-11 acts as a partial androgen-receptor agonist. Research in muscle-cell models has also found that YK-11 can increase follistatin expression, a protein involved in regulating myostatin and other members of the TGF-β family.
This combination makes YK-11 particularly interesting for research focused on muscle differentiation, anabolic signaling, lean-mass development, and myostatin-associated pathways.
Proper Use and Dosage
The listed presentation contains 70 mg of YK-11.
For a 70 mg presentation:
5 mg = 14 administrations
10 mg = 7 administrations
15 mg = approximately 4–5 administrations
20 mg = 3.5 administrations
35 mg = 2 administrations
70 mg = 1 full presentation
For fitness-focused research, YK-11 is primarily associated with lean-muscle development, strength, muscular density, and myostatin/follistatin pathway research.
Benefits
SARMS® Myostatin is particularly suited to advanced research involving muscle growth, strength, anabolic signaling, and myostatin-associated pathways.
Key benefits and areas of interest include:
Supports androgen-receptor activity
Investigated for muscle growth
Supports follistatin-expression research
Relevant to myostatin-associated pathways
Supports muscle-cell differentiation research
Associated with lean-muscle development
May support muscular density and hardness
Relevant to strength-focused training research
Supports advanced anabolic research
Convenient 70 mg presentation
Its distinctive combination of androgen-receptor signaling and follistatin-related activity is what makes YK-11 particularly interesting compared with conventional SARMs.
Side Effects
Potential effects associated with YK-11 may include acne, changes in libido, mood changes, suppression of natural testosterone production, hair-related changes, and changes in liver enzymes or cholesterol. Human clinical safety data are limited because YK-11 has not undergone established human clinical trials.
